Nom du produit:N-(3-chloroquinoxalin-2-yl)-2,3-dihydrobenzo[b][1,4]dioxine-6-sulfonamide
IUPAC Name:N-(3-chloroquinoxalin-2-yl)-2,3-dihydro-1,4-benzodioxine-6-sulfonamide
- CAS:522628-94-0
- Formule moléculaire:C16H12ClN3O4S
- Pureté:95%+
- Numéro de catalogue:CM1050312
- Poids moléculaire:377.8
Pour une utilisation en R&D uniquement..
Détails du produit
- N° CAS:522628-94-0
- Formule moléculaire:C16H12ClN3O4S
- Point de fusion:-
- Code SMILES:ClC1=C(NS(=O)(=O)C2=CC=C3OCCOC3=C2)N=C2C=CC=CC2=N1
- Densité:
- Numéro de catalogue:CM1050312
- Poids moléculaire:377.8
- Point d'ébullition:555.6±60.0 °C at 760 mmHg
- N° Mdl:
- Stockage:
Category Infos
- Quinoxalines
- Quinoxalines, also known as benzopyrazines, are heterocyclic compounds containing a ring complex consisting of a benzene ring and a pyrazine ring. It has isomerism with other naphthalene compounds such as quinazoline, phthalazine, cinnamine, etc. Fusion N-heterocyclic compounds are widely used as valuable entities for the expansion of important pharmacological agents and are considered to be an advantageous scaffold material. Among the numerous fused N-heterocyclic compounds, cinnoline, quinoxaline and quinazoline are important pharmacological agents. In medicinal chemistry, these N-heterocyclic compounds have a wide range of biological properties and can be used as synthetic intermediates, potential drug candidates and chemical probes.